Skip to content
HealthTech Series A Founded 2019

WhiteLab Genomics

Provider of drug discovery and development platform. The platform utilizes AI technology to predict and identify drug candidate molecules for therapeutic purposes. The company was founded in 2019 and headquartered in Paris, France. It has raised $10.6M in series a funding, with backing from Debiopharm, Omnes Capital, Y Combinator, EIT Health. The company operates in the HealthTech - Life Sciences Tech, Life Sciences…

📍 Paris, France · Life Sciences Tech,

Funding snapshot

Last roundSeries A
Amount$10M
Date13 September 2022
Total raised$11M
Team size54

About

Provider of drug discovery and development platform. The platform utilizes AI technology to predict and identify drug candidate molecules for therapeutic purposes. The company was founded in 2019 and headquartered in Paris, France. It has raised $10.6M in series a funding, with backing from Debiopharm, Omnes Capital, Y Combinator, EIT Health. The company operates in the HealthTech - Life Sciences Tech, Life Sciences - Life Sciences Tech, Life Sciences - Genomics space. The company leverages advanced technology to deliver innovative solutions tailored to its target market, addressing key industry challenges and driving value for its customers. With a focus on innovation and market differentiation, the company continues to expand its product offerings and strengthen its competitive position.

Business model

Life Sciences Tech > Research & Development > Drug Discovery > Genomics > Genetic Engineering,

Genomics > Enabling Technologies > Technology Platforms > Genetic Engineering

Institutional investors

Debiopharm Omnes Capital Y Combinator EIT Health

Latest coverage

No articles yet.

Raising like WhiteLab Genomics?

Analyze your pitch deck before your next raise.

Analyze My Deck →